Table of Contents: Oncotarget’s Volume 12, Issue #21
Read short summaries of the latest oncology-focused research published in this week’s issue of&... read more
October 12, 2021
Oncotarget News
Exploration of Gene Editing In The Tumor Setting
Researchers repurposed CRISPR/Cas9 epigenetic editing technology in hopes of characterizing transcriptional changes and effects... read more
October 5, 2021
Trending With Impact: Unconventional Method Effectively Targets NSCLC
In a trending paper published by Oncotarget, researchers developed a divergent strategy to treat non-small... read more
September 30, 2021
New Study: Protein Analysis Reveals Novel Role of Enzyme In Cancer
Researchers discovered an enzyme, originally known to regulate the TGF-β, has a previously unreported role... read more
September 30, 2021
Table of Contents: Oncotarget’s Volume 12, Issue #20
Read short summaries of the latest oncology-focused research published in this week’s issue of... read more
September 28, 2021
Behind the Study: Populations of Cells Resistant to EMT
Dr. Herbert Levine and Dr. Mohit Kumar Jolly describe their research that... read more
September 27, 2021
Behind the Study: Evaluations in TRAMP Prostate Cancer Model
Dr. Yves Chabu from the Department of Biological Sciences at the University of Missouri describes... read more
September 20, 2021
Oncotarget Testimonial: Dr. Yves Chabu
Below is a transcript of the testimonial by Dr. Yves... read more
September 17, 2021
New Study: Nanoparticles Target Acute Myeloid Leukemia
Researchers developed a nanoparticle-based T cell engager (nanoTCE) technology believed to be capable of targeting... read more
September 15, 2021
Table of Contents: Oncotarget’s Volume 12, Issue #19
Read short summaries of the latest oncology-focused research published in this week’s issue of... read more
September 14, 2021